Komunikaty PR

Stealth-ISS Group Inc. Captures Prestigious 2025 RSA Conference Awards for Innovative Cybersecurity Solutions

2025-05-02  |  08:55:05
Dasha Davies

Robert Davies

Stealth-ISS Group Inc.

Stealth-ISS Group Inc Cybersecurity

GRC RIsj Management

Stealth-ISS Group Inc. has received two distinguished awards at the 2025 RSA Conference, reinforcing its position at the forefront of cybersecurity.

SAN FRANCISCO, CA, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- Stealth-ISS Group Inc. (www.stealth-iss.com), a recognized leader in comprehensive cybersecurity solutions and advanced threat intelligence, is pleased to announce it has received two distinguished awards at the 2025 RSA Conference in San Francisco, reinforcing its position at the forefront of the cybersecurity industry.

Stealth-ISS Group was honored with the following prestigious recognitions:
• Best Solution: Cybersecurity-as-a-Service (CaaS)
• Cutting Edge: Risk Management

These awards, presented during the industry's premier cybersecurity event, highlight organizations demonstrating exceptional innovation in addressing evolving digital threats and providing robust security solutions. The awards ceremony took place during the RSA Conference Expo 2025, where industry leaders gathered to recognize outstanding contributions to enterprise security.

Stealth-ISS Group earned recognition for its innovative approach to delivering comprehensive security solutions that address the increasingly complex threat landscape, particularly in the era of advanced AI-driven attacks and sophisticated threat vectors.
"As artificial intelligence continues to reshape the cybersecurity landscape, we're witnessing an exponential increase in both the sophistication and frequency of cyber threats," stated Robert Davies, CEO of Stealth-ISS Group Inc. "Our Best Solution award for Cybersecurity-as-a-Service reflects our commitment to providing adaptive, scalable security solutions that enable organizations to stay ahead of evolving threats while optimizing their security investments. We've designed our CaaS offering specifically to help businesses navigate this new frontier of AI-enhanced threats with confidence and resilience."

Stealth-ISS Group's CaaS solution delivers a comprehensive security ecosystem that combines advanced threat detection, proactive monitoring, and incident response capabilities in a flexible subscription model, making enterprise-grade security accessible to organizations of all sizes.
The company's cutting-edge Risk Management solutions incorporate AI-powered analytics, threat intelligence, and automated compliance frameworks to provide clients with unprecedented visibility into their security posture and potential vulnerabilities.

"The recognition for our Risk Management platform underscores the critical importance of proactive risk mitigation in today's threat environment," said Dasha Davies, President/CISO of Stealth-ISS Group Inc. "With AI technologies dramatically accelerating the attack surface, organizations face unprecedented challenges in identifying and addressing security gaps. Our platform leverages advanced analytics and machine learning to help clients quantify their exposure, prioritize remediation efforts, and implement continuous monitoring solutions that minimize business impact. In this new era where AI is both a powerful security tool and a significant risk multiplier, we're dedicated to providing clients with the intelligence and capabilities they need to protect their most critical assets."

Stealth-ISS Group continues to innovate across its service portfolio, with recent enhancements including:
• AI-enhanced threat hunting and behavioral analytics
• Advanced supply chain security assessment frameworks
• Quantum-resistant encryption implementation services
• Comprehensive AI security governance programs
• Automated compliance management for emerging regulatory standards

These awards highlight Stealth-ISS Group's ongoing commitment to delivering innovative, effective cybersecurity solutions that protect organizations against increasingly sophisticated threats in an AI-accelerated risk landscape.

About Stealth-ISS Group® Inc.
Stealth-ISS Group® Inc., established in 2002 and headquartered in Tampa, FL, is a privately-owned Woman-Owned and Service-Disabled Veteran Owned Small Business providing comprehensive cybersecurity services with a focus on advanced threat protection, vulnerability management, and regulatory compliance. The company delivers Security Consulting and Audit services, Professional Cybersecurity Engineering, and U.S.-Based 24/7 Security Operations with sophisticated threat detection and incident response capabilities.

Stealth-ISS Group holds GSA MAS authorization including all Cyber (HACS) SINs, NATO BOA, and is a CMMC C3PAO organization. The company was recognized on the Inc. 500 list in 2018 and 2019 and ranked in the Top10 on the VET50 list in 2019.

Website: www.stealth-iss.com

Sarah Addams
Stealth-ISS Group Inc.
+1 866-500-0751
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 03:55:06

NEXCOM EBC 370 Powers Autonomous Robotics for Industrial Applications

Highly Efficient, Edge AI Computing Delivered in a Compact New CPUThe EBC 370/EBC 370X is an AI-powered, PC-based controller designed to adapt to the most demanding conditions. Research labs use it as the main control unit for advanced robotics
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 03:55:06

The End Brain Cancer Initiative Partners with Curis to Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial

The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial REDMOND, WA, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- FOR IMMEDIATE RELEASE Contact: Dellann Elliott Mydland, 425-785-8489, Dellann@EndBrainCancer.org The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial The End Brain Cancer Initiative (EBCI) has partnered with Curis to promote awareness and pre-qualify patients for the company’s TakeAim Lymphoma Clinical Trial (CA-4948-101) clinical trial, an open-label, dose escalation and expansion trial of Emavusertib in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/​R PCNSL) (NCT03328078). “We are proud to partner with the End Brain Cancer Initiative to help raise awareness for primary CNS lymphoma (PCNSL), a rare and challenging form of cancer non-Hodgkin lymphoma. Together, we aim to highlight the unmet medical needs of this patient community, provide relevant resources to patients and their care providers, along with increasing awareness of clinical trials,” shared the Chief Medical Officer of Curis Inc, Ahmed Hamdy, MD. “Curis is committed to developing emavusertib for the treatment of PCNSL and broader non-Hodgkin lymphoma indications.” Patients who would like to learn more about this clinical trial and see if they qualify can visit https://endbraincancer.org/curis-therapeutics/ or contact the End Brain Cancer Initiative’s Clinical Research Coordinator and Patient Navigator, Shreya Prakash, at Shreya@EndBrainCancer.org or 425-436-8688. About Curis Curis, located in Lexington, Massachusetts, is a biotechnology company focused on the development of Emavusertib, an orally available, small molecule IRAK4 inhibitor. Emavusertib is currently being evaluated in the TakeAim Lymphoma Phase 1/2 study (CA-4948-101) in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the TakeAim Leukemia Phase 1/2 study (CA-4948-102) in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory high risk myelodysplastic syndrome (hrMDS), and as a frontline combination therapy with venetoclax and azacitidine in patents with AML (CA-4948-104). Emavusertib has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of PCNSL, AML and MDS and from the European Commission for the treatment of PCNSL. Curis, through its 2015 collaboration with Aurigene, has the exclusive license to Emavusertib (CA-4948). Curis licensed its rights to Erivedge® to Genentech, a member of the Roche Group, under which they are commercializing Erivedge® for the treatment of advanced basal cell carcinoma. For more information, visit Curis's website at https://www.curis.com/. About the End Brain Cancer Initiative To support/donate to the End Brain Cancer Initiative’s increased access and health delivery for patients, mission, services and programs, please visit EndBrainCancer.org The End Brain Cancer Initiative (EBCI) is a 501(c)3 non-profit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving Standard of Care. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund (CEF), is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists, and clinical trial participation. We believe that IMMEDIATE ACCESS to these options provides this patient community with the best HOPE for survival and sustained quality of life. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers so they can have empowered conversations with their medical teams. Learn more about the End Brain Cancer Initiative or how to sponsor this annual campaign at EndBrainCancer.org. Dellann Elliott Mydland, End Brain Cancer Initiative, 425-785-8489, Dellann@EndBrainCancer.org
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 02:55:04

Uncle Sharkii Poke Bar Franchisees Honored with Multi-Unit Mastery Award

Uncle Sharkii franchisees Bruno and Jessica Picelli with the 2024 Multi-Unit Mastery Award.The award recognizes the longtime franchisees’ successful leadership and operational excellence across five Uncle Sharkii Poke Bar locations.From day

Kalendarium

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Kongres Profesjonalistów Public Relations

Ochrona środowiska

Z powodu braku przejrzystego prawa branża recyklingu odkłada inwestycje. Firmy apelują o szybkie wdrożenie przepisów

Branża recyklingu stoi przed wyzwaniami związanymi z wdrożeniem systemu kaucyjnego, systemu rozszerzonej odpowiedzialności producenta i rozporządzenia PPWR. Brakuje jednak odpowiednich przepisów dostosowujących polskie prawo i realia do unijnych regulacji. W efekcie utrzymującej się niepewności prawnej między 2018 a 2023 rokiem co trzeci zakład recyklingu zamknął działalność. Wiele firm odkłada inwestycje, czekając na uregulowanie rynku. Podobna niepewność dotyczy też producentów opakowań. 

Transport

Testowanie pojazdów zautomatyzowanych wkrótce będzie możliwe. To odpowiedź na postulaty przedsiębiorców

Kończą się prace nad przepisami, które mają usprawnić prace badawcze nad pojazdami zautomatyzowanymi. Ma to być odpowiedź na postulaty przedsiębiorców, którzy wskazywali na potrzebę pilnej zmiany przepisów w zakresie testowania pojazdów autonomicznych. Obecne regulacje nie sprzyjają postępowi technologicznemu i rozwoju autonomiczności pojazdów, o czym świadczy bardzo niewielka liczba wydanych uprawnień do ich prowadzenia.

Firma

Przedsiębiorcom coraz bardziej doskwiera niestabilność i skomplikowanie przepisów podatkowych. Problemem są też niejasne ich interpretacje

Polscy przedsiębiorcy często negatywnie oceniają jakość przepisów podatkowych – wynika z raportu „Przedsiębiorcy pod lupą fiskusa 2025” przygotowanego przez firmę doradztwa podatkowego MDDP we współpracy z Konfederacją Lewiatan. Ich niepokój budzą niejednolite interpretacje przepisów i niepewność prawa podatkowego, które cały czas jest modyfikowane. Wśród kluczowych zmian w obszarze podatków, które będą dotyczyć praktycznie wszystkich przedsiębiorców, są m.in. wprowadzenie Krajowego Systemu e-Faktur czy zmiany w podatku od nieruchomości.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.